Item 8.01 Other Events.
On January 18, 2022, Turning Point Therapeutics, Inc. (the "Company") issued a
press release announcing business updates, anticipated 2022 clinical and
discovery pipeline milestones and its cash, cash equivalents and marketable
securities balance as of December 31, 2021. A copy of the press release is filed
herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated
herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Press Release issued by Turning Point Therapeutics, Inc. on January 18,
2022.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses